James A Haley Veterans Hospital
Tampa, Florida, 33511, United States
Location status: Recruiting
NCT Number: NCT05254574
The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
Interested in participating?
Request Info35 year–85 year
All sexes
Interventional
Phase 1
Tampa, Florida, 33511, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm@ with 2.5% Diclofenac patches.
Other names: ZetrOZ Ultrasound Device, Wearable Ultrasound Device, Long Duration Ultrasound, LITUS DeviceWearable, Long Duration Low-Intensity Device
Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.
Time frame: Through study completion, average of 8 weeks
Change in the self described pain units on a scale by patient at baseline and post-
Time frame: Time Frame: Through study completion, average of 8 weeks
WOMAC questionnaire will be utilized (Western Ontario and McMaster Universities Arthritis Index) at baseline and post-treatment to calculate the change in scores. WOMAC was divided into 3 categories: pain, stiffness, function and total score. The pain category consists of five scores from 0 - 4, 0 being no pain 4 is worst pain possible, for a range of 0 - 20 points. The stiffness category consists of two scores from 0 - 4, 0 being no stiffness 10 is worst stiffness possible for a range of 0 - 8 points. The function score consists of 17 scores from 0 - 4, 0 being normal function and 10 is severely limited function, for a range of 0 - 68 points. Total score is the sum of pain, stiffness, and function scores (range of 0 - 96).
Time frame: Through study completion, average of 24 weeks.
Subject-reported change in overall pain on a scale, -7 = worst, +7 = best.
Time frame: Through study completion, average of 24 weeks.
Subject-reported rating of impact of pain on sleep on a scale from 0 no impact, to 100 greatest impact
Time frame: Through study completion, average of 24 weeks.
Subject-reported measures of depression, anxiety, and stress on a scale of 0-3, 0 being not applicable, 1 meaning applicable to some degree, 2 meaning applicable often, and 3 meaning applicable most of the time. Questions are divided into three categories: depression, anxiety, and stress.
Contact information is provided by the study sponsor or research team.
ZetrOZ, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07069179
Arthritis, Behavior
Vancouver, British Columbia, Canada
View Trial DetailsNCT06650631
Agnosia, Arthritis
Gravesano, Switzerland
View Trial DetailsNCT06965452
Arthritis, Back Pain
Manhasset, New York, United States
View Trial DetailsNCT06825650
Arthritis, Back Pain
Ankara, Altındağ, Turkey (Türkiye)
View Trial Details